Supporters of SIP

The ‘Societal Impact of Pain’ (SIP) platform is a multi-stakeholder partnership led by the European Pain Federation EFIC and Pain Alliance Europe (PAE). The scientific framework of the SIP platform is under the responsibility of EFIC and the strategic direction of the project is defined by both partners. The pharmaceutical companies Grünenthal GmbH and GSK – GlaxoSmithKline Biologicals SA, are the main sponsors of the Societal Impact of Pain (SIP) platform. The SIP partners are open to new and additional sponsors who wish to support the objectives of the SIP platform. For further information, please contact: